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Background. Sphincter of Oddi manometry is a highly specialized procedure associated with an increased risk of procedural
complications. Published studies have typically been performed in large volume manometry centers. Objective. To examine the
outcomesandcomplicationrateofSOMwhenperformedinsmallvolumes.Design.Retrospectiveanalysisatatertiarycarereferral
hospital that infrequently performs Sphincter of Oddi manometry. Patient records were reviewed for procedural details, patient
outcomes, and complications after sphincter of Oddi manometry. Results. 36 patients, 23 (23 type II sphincter of Oddi dysfunction
(SOD), 13 type III SOD) underwent sphincter of Oddi manometry and were followed up for mean of 16 months. Nine Type II
patients (90%) with elevated basal sphincter pressures noted symptom improvement after sphincterotomy compared with only
3 patients (43%) of the patients with normal basal pressures. In type III SOD, 7 patients had elevated basal SO pressure and
underwent sphincterotomy. Three patients (43%) improved. There were six (16%) procedure-related complications. There were
four cases of post ERCP pancreatitis (11%), all of which were mild. Conclusion. In low numbers, sphincter of Oddi manometry
can be performed successfully and safely by experienced biliary endoscopists with results that are comparable to large volume
centers.
1.Introduction
Sphincter of Oddi dysfunction (SOD) is a term used to
describe epigastric or right upper quadrant pain syndromes
attributed to dyskinesia or stenosis of the sphincter of Oddi.
It is also commonly termed postcholecystectomy syndrome.
Data has suggested that in patients with sphincter of Oddi
stenosis, endoscopic sphincterotomy may be of symptomatic
beneﬁt [1, 2]. However, identifying this patient population
remains a challenge for physicians, both clinically and in
research endeavors. Part of this challenge is the realization
that SOD is likely a heterogenous group of disorders,
inﬂuenced by other factors including psychological stressors,
and overlaps with functional GI disorders including irritable
bowel syndrome [3, 4]. Presently, patients with suspected
SOD are stratiﬁed into three diﬀerent categories based on
objective laboratory and radiologic ﬁndings coupled with
pain [1, 5, 6].
Endoscopic retrograde cholangiopancreatography (ER-
CP)withsphincterofOddimanometry(SOM)isconsidered
the “gold standard” in the diagnosis of SOD. Sphincter
hypertension, deﬁned as basal sphincter pressures above
40mmHg, is considered manometric evidence of SOD [7].
Current standard of practice is to perform endoscopic
sphincterotomy without manometry in patients classiﬁed
as type I SOD. These patients are felt to have papillary
stenosis and will beneﬁt from sphincterotomy without
further investigation [8]. In patients categorized as type II
SOD,documentationofabnormalbiliarysphincterpressures
with SOM is advised before proceeding to sphincterotomy.
This recommendation is based largely on two randomized
clinicaltrials[1,2].TypeIIISODisanevenmorechallenging
clinical situation as these patients lack objective evidence
of sphincter dysfunction and tend to have overlap with
underlying functional disorders, such as irritable bowel
syndrome [3, 4]. Current recommendations suggest that2 Diagnostic and Therapeutic Endoscopy
complete noninvasive diagnostic testing and empiric trials
with antispasmotics or antidepressants be attempted prior
to consideration of SOM [5, 6]. Despite the above research,
controversy remains regarding SOD and the use of SOM as a
diagnostic tool.
ERCP with SOM is considered to have a signiﬁcant risk
of postprocedural complication. The most highly publicized
and feared complication of SOM is post-ERCP pancreatitis.
Research has shown this risk to be higher than the general
population, with risk ranging from as low as 3% all the way
up to greater than 20% [9, 10]. In addition to risks speciﬁc
to SOM, other standard risks of ERCP also are problematic,
including post-sphincterotomy hemorrhage, infection, and
perforation [11].
To date, the vast majority of research regarding SOM has
occurredathigh-volume SOMcenterswithspeciﬁc expertise
and interest in the performance and interpretation of SOM.
Therefore, the applicability and reproducibility of published
data outside of such institutions where SOM is frequently
performed and studied is unclear. Further given the risk of
SOM and complexity, it has been suggested that its perfor-
mance be limited to those performing sphincter manometry
in high numbers. The purpose of this study was to examine
patient outcomes and postprocedural complication risk of
SOM when performed infrequently in low volumes.
2. Methods
2.1. Study Design and Patient Selection. Patients underwent
ERCP with SOM from January 2003 to July 2009. The
patient’s electronic medical records were reviewed to deter-
mine prior radiology and laboratory data, medical therapy
(i.e., tricyclic antidepressants (TCA), selective serotonin
reuptake inhibitors (SSRI), antispasmotics (i.e., dicyclo-
mine), opioids) before and after ERCP, technical success of
the procedure, manometric ﬁndings, whether sphinctero-
tomy was performed, presence and severity of postprocedure
complications, improvement of symptoms, and duration of
followup. The University of Wisconsin IRB approved this
protocol.
2.2. Procedure Details. All patients underwent ERCP using a
Pentaxside-viewingduodenoscope(Model:ED3490TKand
ED 3270 K, Pentax of America Inc., Montvale, NJ). ERCP
and manometry was performed by a single, experienced
biliary endoscopist that performs in excess of 400ERCPs
per year. Twenty-nine patients underwent SOM with general
anesthesia. Seven patients underwent SOM under conscious
sedation.
Once the duodenoscope was in place opposite the major
papilla, SOM was performed using the following protocol.
A manometry catheter (Cook Scientiﬁc SOM 18-L-Lehman-
NG Manometry Catheter, Wilson-Cook Medical, Winson-
Salem, NC) was inserted into the bile duct, measuring
intraductal pressures. Basal sphincter pressures were then
measured with standard station pull-through technique.
Three pull-throughs were performed with sustained basal
sphincter pressure measurements obtained from both the
proximal and distal sensors. Mean basal sphincter pressure
was calculated from the basal sphincter pressures obtained
during each pull-through. If mean basal sphincter pres-
sure was greater than 40mmHg, sphincterotomy was then
performed. If mean basal sphincter pressure was less than
40mmHg, empiric sphincterotomy was performed under
the discretion of the performing endoscopist based on
patient symptoms, duration of symptoms, and severity of
symptoms. Pancreatic duct stenting was done at the endo-
scopist’s discretion. Generally if the pancreatic duct was not
injected and the bile duct was cannulated in 1–3 attempts a
pancreatic stent was not placed.
2.3. Variables Collected. Prior to SOM, laboratory and rad-
iology results were reviewed including previous liver func-
tion tests, abdominal ultrasonographic procedures, CT
scans, MRIs, or MRCPs. Patients were then classiﬁed as
sphincter of Oddi type I, II, or III based on Rome III revised
Milwaukee Group Classiﬁcation [5, 6]. For biliary SOD,
patients were deﬁned as Type I SOD if they noted biliary-
type pain associated with an elevated alkaline phosphatase,
aminotransferase, or total bilirubin greater than two times
the upper limit of normal (ULN) and evidence of a dila-
ted common bile duct (CBD) greater than 10mm on
noninvasive imaging and were not included in this study.
Patients were classiﬁed as Type II SOD if they had pain with
only laboratory abnormalities or imaging abnormalities.
They were classiﬁed as Type III SOD if they had pain but no
laboratory or imaging abnormalities.
At the time of ERCP with SOM, the variables col-
lected were successful cannulation rate, ability to perform
manometric measures, the mean basal sphincter pressure
recorded by manometry, whether or not sphincterotomy was
performed, and whether a pancreatic duct stent was placed.
Postprocedure, the variables collected were postprocedu-
ral complications and their severity as assessed by consensus
criteria [11]. The postprocedural complications that were
examined were post ERCP pancreatitis, perforation, post
sphincterotomy bleeding, cholangitis, and admission to
the hospital post-procedure. Complications were identiﬁed
either immediately after procedure, at a 24hour post proce-
dure call back, or at 30 days through a chart review.
Finally, patient outcomes were assessed based on symp-
tomatic improvement expressed by the patient in clinic
followup. The patient symptom improvement was catego-
rized as no response, partial response, or complete response
based on patient reporting. Symptoms were categorized
based on their symptoms at last known followup. This was
done primarily to account for any placebo eﬀect seen after
performance of sphincterotomy.
2.4. Statistical Analysis. T h ep r i m a r yo u t c o m ea n a l y z e d
was improvement in patient symptoms with endoscopic
sphincterotomy. For the purpose of this analysis, patients
were grouped according to sphincter of Oddi type and then
by presence or absence of sphincter hypertension. Fisher’s
exact test was then used to compare the proportion of
patients with symptom relief after sphincterotomy.Diagnostic and Therapeutic Endoscopy 3
36 patients included
mean age 41years
84% female
23 patients type II SOM 13 patients type III SOM
48 patients underwent
ERCP with SOM
12 excluded
10 no followup
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Figure 1: Patient inclusion and demographics by sphincter of Oddi
dysfunction type.
2.5. Exclusion Criteria. Patients were excluded from the
analysis if they were classiﬁed Type I SOD given current rec-
ommendationsforthesepatientstoundergosphincterotomy
given the high concordance with SOD. Patients were also
excluded if they had no followup or inadequate followup to
document response to treatment/sphincterotomy.
3. Results
3.1. Patient Characteristics. Forty-eight patients underwent
SOM during the study period (mean of 7.38 cases per
year). Thirty-six patients were included in the ﬁnal analysis
becausetheyhadcompletefollow-updata(Figure 1).Thirty-
one (84%) were female with a mean of 41 years of age.
Twenty-three patients (64%) were classiﬁed as type II SOD,
while 13patients (36%) were classiﬁed as type III SOD.
Cannulation rate was 100% with the ability to carry out
sphincter of Oddi manometry in all patients studied. After
SOM,patients were followedfora meanof 16 months (range
of 1–45 months).
3.2. Manometry Results and Patient Outcome
3.2.1. SOD type II. Of the 23 patients classiﬁed as type II
SOD, 10 had a mean basal sphincter pressure of greater
than 40mmHg during SOM (Table 1). All ten of these
patients underwent endoscopic sphincterotomy at the time
of ERCP. Nine (90%) patients experienced sustained subjec-
tive improvement in symptoms with sphincterotomy at time
of last followup. Three patients had complete resolution of
their pain, 6 had some degree of improvement in pain, and 1
patient experienced no relief in symptoms.
Of the remaining 13 SOD type II patients that had
basal sphincter pressures less than 40mmHg, 7 (54%) had
a sphincterotomy performed. In contrast to type II SOD
patientswithelevatedbasalsphincterpressures,only3(43%)
with sphincter pressures less than 40 who underwent a
sphincterotomy experienced any improvement in symptoms
in followup (90% versus 43%, P = .10). One patient
in this group experienced complete symptoms resolution
(30% versus 14%, P>. 50). In comparison, two (33%) of
the 6 patients with pressures less than 40mmHg in which
sphincterotomy was not performed experienced symptom
improvement during the follow-up period. This patient
population was managed medically with therapy aimed at
treating functional abdominal pain.
3.2.2. SOD type III. Thirteen patients had been classiﬁed
as SOD type III (Table 1). Seven subsequently were found
to have elevated basal SO pressures and all underwent
endoscopic sphincterotomy. Of these 7 patients, 3 (43%)
had symptomatic improvement after sphincterotomy. Six
patients did not have manometric evidence of elevated basal
sphincter pressures. However, two patients did undergo
sphincterotomy and one patient did report an improve-
ment in symptoms (Pv a l u e>.50). Among the remain-
ing four patients who did not undergo sphincterotomy,
none experienced an improvement in symptoms during
followup.
3.3. Medical Therapy. Prior to SOM, 26 (72.2%) patients
were on some form of medical therapy. Of the 26 patients,
18 (78.3%) patients had type II SOD and 8 (61.5%)
patients had type III. Postprocedure, 29 patients were on
medical therapy at last followup. All 10 patients that did not
undergo sphincterotomy were on medical therapy. Of the
26 patients that underwent sphincterotomy, seven patients
(6 type II SOD, 1 type III SOD) got oﬀ of medication
for functional pain altogether. Nine patients remained on
medical therapy but experienced improvement in symptoms
after sphincterotomy (6 type II SOD, 3 type III SOD). The
remaining10patients(5typeIISOD,5typeIIISOD)didnot
beneﬁtfromsphincterotomyandwereallonmedicaltherapy
a tt h ee n do fs t u d y .
3.4. Complications. Six patients (16%) had postprocedural
complications. Four patients (11%) had post-ERCP pan-
creatitis. All four cases were considered mild by consensus
criteria published by Cotton et al., in 2009 [11]. All four
patients were discharged from the hospital within 48 hours
of admission and recovered without sequelae. One patient
(2.8%) had a moderate postsphincterotomy hemorrhage.
She was hospitalized and required transfusion of three units
of packed red blood cells. One patient (2.8%) developed
moderate cholangitis post-procedure. During her initial
procedure, she was found to have normal basal sphincter
pressures and no intervention was performed. However, over
the next 24 hours she became febrile to 38.6 degrees Celsius.
Her serum total bilirubin rose 5.9mg/dL. She underwent
repeat ERCP, and a sphincterotomy was performed. She
recovered without sequelae. Of note, three patients did
have pancreatic duct stents placed at the time of ERCP
in an attempt to avoid post-ERCP pancreatitis. One of
these patients was one of the four patients that developed
pancreatitis. Finally, nine patients (25%) were admitted
to the hospital for postprocedural abdominal pain. None
of these patients had objective evidence of pancreatitis,
cholangitis, or perforation. Seven of these patients were type
II SOD and 2 were type III SOD. Seven had undergone
biliary sphincterotomy during the procedure. SOD type and
performance of sphincterotomy were not associated with
probability of postprocedural pain. All nine patients were
discharged within 48 hours.4 Diagnostic and Therapeutic Endoscopy
Table 1: Clinical outcomes of patients stratiﬁed by SOD type, manometric ﬁndings, and whether sphincterotomy was performed.
SOD type Mean basal SO pressure N
Symptom
improvement
(%)
P value
SOD type II >40mmHg (total) 10 90
Sphincterotomy 10 90
No sphincterotomy 0 n/a .10
<40mmHg (total) 13 38
Sphincterotomy 7 43
No sphincterotomy 6 33
SOD type III >40mmHg (total) 7 43
Sphincterotomy 7 43
No sphincterotomy 0 n/a >.50
<40mmHg (total) 6 17
Sphincterotomy 2 50
No sphincterotomy 4 0
4. Discussion
The diagnosis and management of patients with sphincter
of Oddi dysfunction remains a challenge and a contro-
versy for gastroenterologists. Principle to that challenge is
determining which patient population may beneﬁt from
endosocopic sphincterotomy. In addition to classiﬁcation
systems based on objective data, randomized studies have
suggested that SOM is beneﬁcial in the identiﬁcation of
true sphincter hypertension and thus potential beneﬁt from
sphincterotomy[1,2].Studyingsphincterotomyversussham
procedure, Geenen et al. showed a 91% of patients classiﬁed
as type II SOD with sphincter hypertension beneﬁtted
symptomatically from sphincterotomy [1]. Toouli et al.
showed a beneﬁt of sphincterotomy only in patients with
sphincter hypertension [2]. Despite the promising data in
these randomized studies, skepticism remains regarding the
accuracy and reproducibility of these data. Several nonran-
domized studies have called into question the utility of SOM
in identifying patients that beneﬁt from sphincterotomy and
in the need for manometry in all suspected Type II and
III patients [12, 13]. In addition, research regarding SOM
primarily occurs in centers with extensive experience and
interest in the performance and interpretation of SOM. For
example, in a recently published paper from a single center,
5352 patients had ERCP with SOM over a 13-year period,
averaging over 400 manometry cases per year [14]. Similarly,
in a recent paper from Cotton et al., over a 12-year period
performed over 1300 biliary SOM were performed at one
institution, corresponding to over 100 SOM cases per year
[11]. It is unknown if ERCP with SOM can and should be
performed outside of such large SOM centers.
In this study, we examined the outcomes and safety of
SOM in the diagnosis and treatment of SOD at a center
where SOM is performed far less frequently. In general,
about 7 patients in our institution undergo SOM annually.
Despitethesesmallnumbers,ourdataissimilartopreviously
published data. In our study, those patients classiﬁed as
type II SOD with manometric evidence of sphincter hyper-
tension seemed to beneﬁt from sphincterotomy (Table 1).
Additionally, patients with type II SOD without sphincter
hypertension and patients with type III SOD demonstrated
less demonstrable beneﬁt from sphincterotomy. This data
is in agreement with published guidelines that sphincter
of Oddi manometry is best performed in type II and
Type III SOD with sphincterotomy reserved for those with
documented sphincter hypertension [1, 6]. We also found
that evenwhenrarely performedSOM canbe used to predict
who will have a beneﬁt from endoscopic sphincterotomy.
The overall complication rate of 16% in this study fell
well within expected values with no major complications.
Acute pancreatitis, the most feared complication of SOM,
occuredinonly11%ofpatientsandallofthecasesweremild
being hospitalized for less than 5 days with no sequelae. This
value also falls within previously published rates [9, 10]. It
is important to note however that while our center is a low-
volume SOM center, it is a tertiary referral ERCP center. All
of the ERCPs in this study were performed by an experienced
biliary endoscopist that performs in excess of 400 ERCPs
per year. Previous studies have documented that low ERCP
volumeisassociatedwithanincreasedriskofpostprocedural
complications [15]. Therefore, it should be reinforced that
although abundant experience in the performance of SOM
may not be a necessary prerequisite for SOM safety, whether
SOMeﬀectivenessandsafetycanbereproducedinanycenter
particularly those with overall low volume ERCPs cannot be
deﬁnitively stated.
There are several weaknesses to this study. First is the
nature of the study with a small patient population. We
performed this study with the purpose to see if SOM could
be performed successfully in small numbers but this made
true statistical comparison diﬃcult. While the data trended
toward statistical signiﬁcance, the total population was small
and the data did not reach signiﬁcance. In addition, no
patient followup was available for twelve patients. The main
reason for lack of patient followup is that these patients oftenDiagnostic and Therapeutic Endoscopy 5
were from geographic areas that were signiﬁcantly far from
our center and were referred for SOM. Finally, outcomes
were based on patient perception of symptom improve-
ment. Scoring systems to assess symptom and quality of
life improvement were not used. In addition, as with all
functional intestinal disorders, the impact of placebo eﬀect
cannot be underestimated.
In conclusion, SOM is perhaps the most technically
challenging ERCP procedure in a challenging patient pop-
ulation. Most research on SOM has been performed in large
volume centers with highly experienced gastroenterologists
in the performance and interpretation of SOM. There has
been little research published on SOM in a “real world”
scenario outside of larger research studies and SOM centers.
This study reﬂects that SOM can be performed safely with
acceptable risk in centers that perform SOM infrequently.
In addition, it did reproduce previously published data
suggesting that manometry studied patients with sphincter
hypertension are the most likely population to beneﬁt from
sphincterotomy, and SOM when done in low numbers can
also be eﬀective in the treatment of suspected SOD patients.
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